BBOT Competitors & Alternatives

Compare BridgeBio Oncology Therapeutics, Inc. with similar stocks in the same industry

Biotechnology

BBOT

Main Stock
$8.66
Tradestie Score
53
Market Cap
$952.74M
Analyst Upside
+193.0%

Top Competitors

222 stocks in Biotechnology
Company Price Market Cap P/E Score Action
AVBP ArriVent BioPharma, Inc. Common Stock
$30.13
$748.90M - 61 Compare
TBPH Theravance Biopharma, Inc.
$16.58
$726.21M 8.2 61 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$16.49
$718.62M - 59 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$34.27
$715.25M - 57 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$124.19
$699.30M - 59 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$7.53
$688.47M 381.5 57 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 56 Compare
ARVN Arvinas, Inc
$9.84
$670.30M - 56 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$8.86
$665.30M - 53 Compare

Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)

222 stocks in this industry